Company profile for Galectin Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Galectin Therapeutics is a biotechnology company focused on discovery and development. We apply our leadership in galectin science and drug development to create new therapies to improve the lives of patients with chronic liver and skin diseases and cancer. Drug candidates based on our unique carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function. Galectin Therapeutics lev...
Galectin Therapeutics is a biotechnology company focused on discovery and development. We apply our leadership in galectin science and drug development to create new therapies to improve the lives of patients with chronic liver and skin diseases and cancer. Drug candidates based on our unique carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function. Galectin Therapeutics leverages extensive scientific and development expertise as well as established relationships with outside sources to achieve cost-effective and efficient development.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
4960 Peachtree Industrial Boulevard Suite 240 Norcross, 30071
Telephone
Telephone
678-620-3186
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/14/3188253/27423/en/Galectin-Therapeutics-Reports-Financial-Results-for-the-quarter-ended-September-30-2025-and-Provides-Business-Update.html

GLOBENEWSWIRE
14 Nov 2025

https://www.globenewswire.com/news-release/2025/11/10/3184519/27423/en/Galectin-Therapeutics-Presented-NAVIGATE-Trial-Results-at-the-American-Association-for-the-Study-of-Liver-Diseases-AASLD-2025-Annual-Meeting.html

GLOBENEWSWIRE
10 Nov 2025

https://www.globenewswire.com/news-release/2025/10/20/3169313/27423/en/Galectin-Therapeutics-to-Present-at-the-H-C-Wainwright-9th-Annual-MASH-Investor-Conference.html

GLOBENEWSWIRE
20 Oct 2025

https://www.globenewswire.com/news-release/2025/10/07/3162421/27423/en/Galectin-Therapeutics-to-Present-at-the-American-Association-for-the-Study-of-Liver-Disease-AASLD-Liver-Meeting-2025.html

GLOBENEWSWIRE
07 Oct 2025

https://www.globenewswire.com/news-release/2025/09/02/3142575/27423/en/Galectin-Therapeutics-to-Present-at-the-H-C-Wainwright-27th-Annual-Global-Investment-Conference.html

GLOBENEWSWIRE
02 Sep 2025

https://www.globenewswire.com/news-release/2025/08/14/3133433/27423/en/Galectin-Therapeutics-Reports-Financial-Results-for-the-Quarter-Ended-June-30-2025-and-Provides-Business-Update.html

GLOBENEWSWIRE
14 Aug 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty